Search research articles
Contact Us
Filters
Showing results (71-80 of 372) with videos related to
Page
of 38
Sort By:
Nature Reviews. Cancer
|
October 2, 2025
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
Alfred Zippelius, Sara M Tolaney, Paolo Tarantino, et al.
The Oncologist
|
September 26, 2025
Clinical perspective on management of key adverse events with sacituzumab govitecan
Sara M Tolaney, Guru P Sonpavde, Paolo Tarantino, et al.
Future Oncology (London, England)
|
October 3, 2023
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer: plain language summary of the monarcHER study
Sara M Tolaney, Shom Goel, Adams Kusi Appiah, et al.
Current Oncology Reports
|
January 10, 2024
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Fei Song, Paolo Tarantino, Ana Garrido-Castro, et al.
Oncology and Therapy
|
July 24, 2020
Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia
Lindsay L Peterson, Maryam Lustberg, Sara M Tolaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2023
Reply to Y. Yoshitomi et al
Sara M Tolaney, Elisabeth De Kermadec, Patrick Cohen, et al.
Cancer Treatment Reviews
|
March 9, 2023
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review
Volkmar Müller, Rupert Bartsch, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer
Sara M Tolaney, Ann H Partridge, Rochelle G Sheib, et al.
Breast Cancer Research and Treatment
|
January 9, 2022
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer
Yee-Ming M Cheung, Grace E Cromwell, Sara M Tolaney, et al.
The Lancet. Oncology
|
May 5, 2023
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer - Authors' reply
Stephen R D Johnston, Sara M Tolaney, Joyce O'Shaughnessy, et al.
Page
of 38
Search research articles
Search
Showing results (71-80 of 372) with videos related to
Sort By:
Page
of 38
Nature Reviews. Cancer
|
October 2, 2025
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
Alfred Zippelius, Sara M Tolaney, Paolo Tarantino, et al.
The Oncologist
|
September 26, 2025
Clinical perspective on management of key adverse events with sacituzumab govitecan
Sara M Tolaney, Guru P Sonpavde, Paolo Tarantino, et al.
Future Oncology (London, England)
|
October 3, 2023
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer: plain language summary of the monarcHER study
Sara M Tolaney, Shom Goel, Adams Kusi Appiah, et al.
Current Oncology Reports
|
January 10, 2024
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Fei Song, Paolo Tarantino, Ana Garrido-Castro, et al.
Oncology and Therapy
|
July 24, 2020
Integration of Physician and Nursing Professional Efforts to Deliver Supportive Scalp Cooling Care to Oncology Patients at Risk for Alopecia
Lindsay L Peterson, Maryam Lustberg, Sara M Tolaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 30, 2023
Reply to Y. Yoshitomi et al
Sara M Tolaney, Elisabeth De Kermadec, Patrick Cohen, et al.
Cancer Treatment Reviews
|
March 9, 2023
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review
Volkmar Müller, Rupert Bartsch, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 23, 2006
Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer
Sara M Tolaney, Ann H Partridge, Rochelle G Sheib, et al.
Breast Cancer Research and Treatment
|
January 9, 2022
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer
Yee-Ming M Cheung, Grace E Cromwell, Sara M Tolaney, et al.
The Lancet. Oncology
|
May 5, 2023
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer - Authors' reply
Stephen R D Johnston, Sara M Tolaney, Joyce O'Shaughnessy, et al.
Page
of 38